IFNG and rheumatoid arthritis: In addition, abatacept, which is employed in adult RA and is also approved for the treatment of juvenile idiopathic arthritis was shown to reduce the proliferation of T-helper cells from healthy donors in response to recall antigens as well as reducing the level of IFN-γ and TNF-α in vitro [23].